European Journal of Pharmacology

Modulation of 5-HT receptor subtype-mediated behaviours by corticosterone
pp. 103-111(9)
Authors: Berendsen H.H.G.; Kester R.C.H.; Peeters B.W.M.M.; Broekkamp C.L.E.

Facilitation and attenuation of social recognition in rats by different oxytocin-related peptides
pp. 113-116(4)
Authors: Popik P.; Vetulani J.; Van Ree J.M.

Parasympathetic inhibition of pineal indole metabolism by prejunctional modulation of noradrenaline release
pp. 117-124(8)
Authors: Drijfhout W.J.; Grol C.J.; Westerink B.H.C.

Effect of pertussis toxin on morphine, diphenhydramine, baclofen, clomipramine and physostigmine antinociception
pp. 125-133(9)
Authors: Galeotti N.; Ghelardini C.; Bartolini A.

Pharmacology of N-methyl-d-aspartate-evoked [³H]noradrenaline release in adult rat spinal cord
pp. 135-144(10)
Authors: Klarica M.; Fage D.; Carter C.

Inhibitory effect of phorbol 12,13-dibutyrate on norepinephrine-induced contraction in rabbit iris dilator muscle
pp. 145-152(8)
Authors: Satoh M.; Matsuo K.; Kokubu N.; Takayanagi I.

Functional analysis of opioid receptor subtypes in the ventromedial hypothalamic nucleus of the rat
pp. 153-159(7)
Authors: Chunyi Z.; Pfaff D.W.; Lee-Ming K.

Activation of the cannabinoid receptor by ⁹-tetrahydrocannabinol reduces -aminobutyric acid uptake in the globus pallidus
pp. 161-164(4)
Authors: Maneuf Y.P.; Nash J.E.; Crossman A.R.; Brotchie J.M.

Angiotensin II-induced renal responses in anesthetized rabbits: effects of N-nitro-l-arginine methyl ester and losartan
pp. 165-171(7)
Authors: Adachi Y.; Hashimoto K.; Hisa H.; Yoshida M.; Suzuki-Kusaba M.; Satoh S.

5-HT₃ and 5-HT₄ receptors and cholinergic and tachykininergic neurotransmission in the guinea-pig proximal colon
pp. 173-180(8)
Authors: Briejer M.R.; Schuurkes J.A.J.

Increased defaecation caused by 5-HT₄ receptor activation in the mouse
pp. 181-186(6)
Authors: Banner S.E.; Smith M.I.; Bywater D.; Gaster L.M.; Sanger G.J.

Characterization of the receptor mediating the effect of calcitonin gene-related peptide in the frog adrenal gland
pp. 187-193(7)
Authors: Esneu M.; Delarue C.; Fournier A.; Vaudry H.

Transgenic model for the discovery of novel human secretory non-pancreatic phospholipase A₂ inhibitors
pp. 195-203(9)
Authors: Fox N.; Min S.; Schrementi J.; Sharp J.D.; White D.L.; Snyder D.W.; Hartley L.W.; Carlson D.G.; Bach N.J.; Dillard R.D.; Draheim S.E.; Bobbitt J.L.; Fisher L.; Mihelich E.D.

Effect of glimepiride (HOE 490) on insulin receptors of skeletal muscles from genetically diabetic KK-Ay mouse
pp. 205-210(6)
Authors: Takada Y.; Takata Y.; Iwanishi M.; Imamura T.; Sawa T.; Morioka H.; Ishihara H.; Ishiki M.; Usui I.; Temaru R.; Urakaze M.; Satoh Y.; Inami T.; Tsuda S.; Kobayashi M.

Different characteristics of AMPA receptor agonists acting at AMPA receptors expressed in Xenopus oocytes
pp. 211-218(8)
Authors: Wahl P.; Madsen U.; Banke T.; Krogsgaard-Larsen P.; Schousboe A.

Apomorphine is a highly potent free radical scavenger in rat brain mitochondrial fraction
pp. 219-225(7)
Authors: Gassen M.; Glinka Y.; Pinchasi B.; Youdim M.B.H.